Abstract:Cardiac hypertrophy is characterized by an increase in cell size in the absence of cell division and is accompanied by a number of qualitative and quantitative changes in gene expression. Most forms of hypertrophy in vivo are compensatory or adaptative responses to increased workload resulting from various physiological and/or pathological etiologies. Until severe pathological alterations become apparent, myocytes show no drastic morphological changes. On the level of gene expression, upregulation of the so-called fetal genes, i.e., beta-myosin heavy chain, alpha-skeletal and alpha-smooth muscle actin, and atrial natriuretic factor (ANF) may be observed concomitant with a downregulation of alpha-myosin heavy chain and the Ca pump of sarcoplasmic reticulum. The use of primary cell culture systems for cardiomyocytes as an in vitro model for the hypertrophic reaction has identified a number of different stimuli as mediators of cardiac myocyte hypertrophy. The molecular dissection of the different intracellular signaling pathways involved herein has uncovered a number of branching points to cytosolic and nuclear targets and has identified many interactions between these pathways. The individual administration of these hypertrophic stimuli, i.e., hormones, cytokines, growth factors, vasoactive peptides, and catecholamines, to cultured cardiomyocytes, reveals that each stimulus induces a distinct phenotype as characterized by gene expression pattern and cellular morphology. Surprisingly, triiodothyronine (T3) and basic fibroblast growth factor (bFGF) effect a similar cellular phenotype although they use completely different intracellular pathways. This phenotype is characterized by drastic inhibition of myofibrillar growth and by upregulation of alpha-smooth muscle actin. On the other hand, insulin-like growth factor (IGF) I, a factor promoting muscle cell differentiation, and bFGF, an inhibitor of differentiation, cause completely different cardiomyocyte phenotypes although both are known to signal via receptor tyrosine kinases and have been shown to activate the Ras-Raf-MEK-MAP kinase pathway. However, both IGF-I and bFGF depend on T3 to bring about their typical responses, i.e., T3 is permissive for the action of these two growth factors on the expression of alpha-smooth muscle actin and cell morphology. Most of the hypertrophic stimuli are balanced under normal circumstances in vivo. When this balance is disturbed, however, a pathological heart phenotype may become dominant. Thus the knowledge of signaling pathways and cellular responses triggered by hypertrophic stimuli may be essential for the implementation of therapeutic strategies in the treatment of cardiac hypertrophy.

Identification of Proteins Responding to Adrenergic Receptor Subtype-Specific Hypertrophy in Cardiomyocytes by Proteomic Approaches.

Proteomic Profiling Reveals Comprehensive Insights into Adrenergic Receptor-Mediated Hypertrophy in Neonatal Rat Cardiomyocytes.

Different Roles Of Alpha(1)-Adrenoceptor Subtypes In Mediating Cardiomyocyte Protein Synthesis In Neonatal Rats

Quantitative Analysis of the Cardiac Phosphoproteome in Response to Acute -Adrenergic Receptor Stimulation In Vivo

Differential Proteomic Analysis of Neonatal Cardiomyocytes in Response to Β-Adrenergic Receptor Stimulation

Proteomic analysis of proteins with altered expression induced by phenylephrine in neonatal rat cardiomyocyte

[Effects of Beta-Adrenoceptor Activation on Metabolism in Neonatal Rat Cardiomyocytes].

Phosphoproteome Analysis of Cardiomyocytes Subjected to Β-Adrenergic Stimulation

Effects of Erk1/2/Ppar Alpha/Scad Signal Pathways on Cardiomyocyte Hypertrophy Induced by Insulin-Like Growth Factor 1 and Phenylephrine

Crosstalk between angiotensin II and platelet derived growth factor-BB mediated signal pathways in cardiomyocytes

Roles of ERKs and Intracellular Free Calcium in Cardiomyocyte Hypertrophic Response Induced by Endothelin-1

β2-Adrenergic receptor-induced transactivation of epidermal growth factor receptor and platelet-derived growth factor receptor via Src kinase promotes rat cardiomyocyte survival.

Proteomic Profile in Rat Hypertrophic Myocardium Induced by Abdominal Aortic Constriction

Proteomic Analysis of Hypertrophied Left Ventricle in Spontaneously Hypertensive Rats

Transactivated EGFR Mediates Α₁-Ar-induced STAT3 Activation and Cardiac Hypertrophy.

Cardiac Oxidative Signaling and Physiological Hypertrophy in the Na/K-ATPase α1s/sα2s/s Mouse Model of High Affinity for Cardiotonic Steroids

Cardiac Contractility-Adrenergic β-Adrenergic Receptor Subtypes Optimizes 2 β-and 1 β Heterodimerization of Print

PERK-mediated Endoplasmic Reticulum Stress is Involved in Angiotensin II-induced Myocardial Hypertrophy

Various hypertrophic stimuli induce distinct phenotypes in cardiomyocytes

A Proteomic Approach to Determine Changes in Proteins Involved in the Myocardial Metabolism in Left Ventricles of Spontaneously Hypertensive Rats

Protein kinase C epsilon-dependent extracellular signal-regulated kinase 5 phosphorylation and nuclear translocation involved in cardiomyocyte hypertrophy with angiotensin II stimulation.